Dimenhydrinate

茶苯海明

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameDimenhydrinate
Drug Alias Name捉迷明DimenhydrinatumDimenhidrinato晕海宁曲拉明 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsRadiotherapy induced emesisNauseaMotion Sickness +[6] 
Global Approved IndicationsRadiotherapy induced emesisNauseaMotion Sickness +[6] 
Approved Indications in ChinaNauseaVertigo
Original Approved Country/TerritoryCanada
Original Approved Date1953/12/31
Country/TerritoryCanadaMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChurch & Dwight
China Registration ClassN/A

Develop Information

Active CompaniesChurch & DwightYoshindo IncTianjin Huajin Pharmaceutcial Co Ltd
Inactive CompaniesN/A
Active IndicationsRadiotherapy induced emesisNauseaMotion Sickness +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeA04A
Related LinksWikipediaDrugBankKEGG